Melanoma March physical events in 2022
20 September 2021
We are excited to announce a return to our much-loved physical Melanoma March events next year (COVID restrictions permitting)!
After a two-year hiatus due to COVID, we are looking forward to welcoming back our dedicated community to our physical events across the country.
This will be the 11th year of Melanoma March, and it remains a critical fundraiser to support our national life-saving research under the leadership of Professor Georgina Long AO and Professor Richard Scolyer AO and our many collaborating institutions.
Dates have been set for multiple Melanoma March events and more will be announced in coming months, so please mark the dates in your diary. We can’t wait to welcome you back!
- Western Sydney - 6 March
- Wagga - 13 March
- Manly - 27 March
- Bathurst - date tbc
- Canberra - date tbc
- Melbourne - 20 March
- Bendigo - date tbc
- Brisbane - 13 March
- Rockhampton - date tbc
- Bunbury - 13 March
- Perth - 27 March
- Adelaide - date tbc
- Hobart - 20 March
We'll keep you updated as more locations are added. If you would like to register your interest in participating in an event, and be kept updated via email please go to: melanomamarch.org.au
Together we can take steps to beat melanoma.
Melanoma March is an initiative of Melanoma Institute Australia, incorporating melanomaWA and Amie St Clair. It is proudly supported by Melanoma Patients Australia, Australian Melanoma Research Foundation, Skin Cancer Tasmania and other melanoma research organisations across Australia.
Toyota and country music fans invited to tip their hat to help tackle Australia's national cancer – melanoma
Melanoma Institute Australia has teamed up with the Toyota Country Music Festival 2018 in Tamworth!
MIA's dermatologist shares her knowledge with GPs on debunking myths and controversies on sunscreen.
Shannan Ponton thought he was invincible – he wasn’t. But his melanoma battle ended up saving more than his own life.
Researchers have demonstrated that immunotherapy is highly effective in treating a rare form of melanoma – a result that is surprising due to the nature of the tumour.
Innovation is helping to prevent melanoma developing in the first place.
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
A prestigious Fellowship has been awarded to fund research that will change the way melanoma treatment is assessed in the future.
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.